SLC39A11 and ovarian cancer: Analysis of 2344 samples from 2330 patients found in seven publicly available cervical and ovarian cancer studies (https://www.cbioportal.org/) confirmed that ZIP11 had an alteration frequency of 2–3%, within the genome, with the majority of the genes being amplified or mutated rather than deleted (Figure 1A).